Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Ricardo E. Dent-Acosta
Based on 2 articles published since 2009
(Why 2 articles?)
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 2 published articles on Hypercholesterolemia from 2009 through 2019, it is not possible for Expertscape to reliably rate Ricardo E. Dent-Acosta's expertise on this topic.

Work Locations
Details
Most likely:    Amgen      
2016
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Clinical Development, and Biostatistics, Amgen Inc., Thousand Oaks, California. · The Cardiometabolic Disorders Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit and Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Department of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Department of Cardiology, Hartford Hospital, Hartford, Connecticut. · Pubmed 26946077
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Ricardo E. Dent-Acosta in 2009-2019 about Hypercholesterolemia:

  • Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. 2016
  • Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. 2016
Show List of Full Article Records
Google Searches

Learn more about Ricardo E. Dent-Acosta using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Amgen
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Amgen
2016
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Clinical Development, and Biostatistics, Amgen Inc., Thousand Oaks, California. · The Cardiometabolic Disorders Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit and Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Department of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Department of Cardiology, Hartford Hospital, Hartford, Connecticut. · Pubmed 26946077
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
Yearly article counts 00020000000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.